Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06062368 · ClinicalTrials.gov registry record · NA
Reducing Vertigo Associated With MRI Machines
A NA study of Dizziness and Vertigo, sponsored by Johns Hopkins University.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT06062368: Recruiting NA study of Dizziness and Vertigo, sponsored by Johns Hopkins University.
NCT06062368 is a NA study of Dizziness and Vertigo that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 100 participants, below the 10,091-participant average among 8 other Dizziness trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06062368, a NA study of Dizziness and Vertigo, is actively recruiting participants, sponsored by Johns Hopkins University.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
Vertigo, dizziness, and imbalance are commonly reported by patients and technologists when near high-field strength magnets (\>4 Tesla, T) used for magnetic resonance imaging (MRI) (1-5) Prior research from the investigators has established that the mechanism is likely a Lorentz force occurring in the inner ear, as a result of interactions with normal electrical currents in the inner ear and the strong static magnetic field of the MRI machine. The investigators have recently developed preliminary data to suggest that slower rates of entry into the magnetic field can greatly attenuate the sensations of vertigo. The explanation for this is that the rates of vestibular adaptation exceed that of the stimulus, allowed a reduction or elimination of the symptoms of vertigo. The aim of this study is to recruit individuals who are already getting an MRI scan as part of other research studies to randomize the rate of entry into and exit from the static magnetic field (i.e., before and after imaging is performed). The usual rate of entry is 20 seconds. This will be increased to one, two or three minutes. The investigators will record subjective sensations of dizziness and vertigo associated with the entry into the MRI.
Primary Outcome
Participants will report the presence and intensity of their vertigo. The presence or absence of vertigo for each group will be the primary outcome.
Interventions
- BEHAVIORAL Rate of Entry
Study Locations (1)
Maryland
- Johns Hopkins University School of Medicine - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2024-01-15 |
| Est. Completion | 2028-01-01 |
| Phase | NA |
What NCT06062368 shows while recruiting
NCT06062368 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 10,091-participant average among 8 other Dizziness trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Dizziness appearing as the primary indexed condition, and to 1 intervention - of which Rate of Entry is the first listed.
NCT06062368 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT06062368 about?
NCT06062368 is a clinical study titled "Reducing Vertigo Associated With MRI Machines". Vertigo, dizziness, and imbalance are commonly reported by patients and technologists when near high-field strength magnets (\>4 Tesla, T) used for magnetic resonance imaging (MRI) (1-5) Prior research from the investigators has established that the mechanism is likely a Lorentz force occurring in t...
What is the current status of trial NCT06062368?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2024-01-15. Estimated completion is 2028-01-01.
What conditions does trial NCT06062368 study?
This clinical trial studies the following conditions: Dizziness, Vertigo.
What interventions are being tested in trial NCT06062368?
The interventions under investigation include: Rate of Entry (BEHAVIORAL).
Who is sponsoring clinical trial NCT06062368?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06062368 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dizziness
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06062368's enrollment target sits among peer trials
100 3rd of 8 higher than 5 of 8 other Dizziness trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Dizziness trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Vestibular Rehabilitation App for Adults With Dizziness Related to mTBI
RECRUITING · NA
-
Fall Risk Assessment and Speech Intelligibility Enhancement Using In-ear Device
RECRUITING · NA
-
Implementation of Evidence-Based Practice for Dizziness
ACTIVE NOT RECRUITING · NA
-
Gaze and Postural Stability in Multiple Sclerosis
COMPLETED · NA
-
Vestibular Testing: Consistency and Effects Over Time
COMPLETED · NA
-
"Can A Prescribed Walking Program With or Without Monitoring Impact Dizziness in the Older Adults?"
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI